Literature DB >> 20093126

Improving regenerating potential of the heart after myocardial infarction: factor-based approach.

Hyosook Hwang1, Robert A Kloner.   

Abstract

The emerging evidence that the heart has the potential to regenerate, albeit not ideally, has stimulated considerable interest in the field of cardiac regenerative medicine. Several lines of research demonstrated that factor-based therapy is feasible and effective, whether it is used independently or as an adjunct to cell therapy. The ultimate goal of the factor-based approach is to improve the regenerating potential of the heart as a means to treat patients with cardiovascular disease. This article reviews recent approaches involving factor-based therapy for cardiac repair and regeneration including some of the advantages of this type of therapy as well as some of the hurdles that must be overcome before this therapeutic approach becomes a standard part of clinical medicine. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20093126     DOI: 10.1016/j.lfs.2010.01.004

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  13 in total

Review 1.  The role of neuregulin/ErbB2/ErbB4 signaling in the heart with special focus on effects on cardiomyocyte proliferation.

Authors:  Brian Wadugu; Bernhard Kühn
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

2.  Sequential delivery of angiogenic growth factors improves revascularization and heart function after myocardial infarction.

Authors:  Hassan K Awada; Noah R Johnson; Yadong Wang
Journal:  J Control Release       Date:  2015-03-31       Impact factor: 9.776

3.  Intramyocardial administration of chimeric ephrinA1-Fc promotes tissue salvage following myocardial infarction in mice.

Authors:  Jessica L Dries; Susan D Kent; Jitka A I Virag
Journal:  J Physiol       Date:  2011-01-31       Impact factor: 5.182

Review 4.  Sensing the cardiac environment: exploiting cues for regeneration.

Authors:  Maria José Nunes Pereira; Isabel Fidalgo Carvalho; Jeffrey M Karp; Lino S Ferreira
Journal:  J Cardiovasc Transl Res       Date:  2011-07-07       Impact factor: 4.132

5.  Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI).

Authors:  Rosemeire M Kanashiro-Takeuchi; Lauro M Takeuchi; Ferenc G Rick; Raul Dulce; Adriana V Treuer; Victoria Florea; Claudia O Rodrigues; Ellena C Paulino; Konstantinos E Hatzistergos; Sarah M Selem; Daniel R Gonzalez; Norman L Block; Andrew V Schally; Joshua M Hare
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-27       Impact factor: 11.205

Review 6.  Effect of hypoxia on human adipose-derived mesenchymal stem cells and its potential clinical applications.

Authors:  Jane Ru Choi; Kar Wey Yong; Wan Kamarul Zaman Wan Safwani
Journal:  Cell Mol Life Sci       Date:  2017-02-21       Impact factor: 9.261

Review 7.  Myocardial regeneration of the failing heart.

Authors:  Alexander T Akhmedov; José Marín-García
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

8.  Combination of HGF and IGF-1 promotes connexin 43 expression and improves ventricular arrhythmia after myocardial infarction through activating the MAPK/ERK and MAPK/p38 signaling pathways in a rat model.

Authors:  Jierong Yao; Jianting Ke; Zhijuan Zhou; Guangyi Tan; Yuelan Yin; Mao Liu; Jian Chen; Wei Wu
Journal:  Cardiovasc Diagn Ther       Date:  2019-08

9.  Adipose stromal cells primed with hypoxia and inflammation enhance cardiomyocyte proliferation rate in vitro through STAT3 and Erk1/2.

Authors:  Ewa Przybyt; Guido Krenning; Marja G L Brinker; Martin C Harmsen
Journal:  J Transl Med       Date:  2013-02-13       Impact factor: 5.531

10.  EphA2-receptor deficiency exacerbates myocardial infarction and reduces survival in hyperglycemic mice.

Authors:  Augustin DuSablon; Susan Kent; Anita Coburn; Jitka Virag
Journal:  Cardiovasc Diabetol       Date:  2014-08-13       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.